Quantinno Capital Management LP Buys 64,874 Shares of Align Technology, Inc. $ALGN

Quantinno Capital Management LP increased its stake in Align Technology, Inc. (NASDAQ:ALGN) by 135.2% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 112,859 shares of the medical equipment provider’s stock after buying an additional 64,874 shares during the quarter. Quantinno Capital Management LP’s holdings in Align Technology were worth $19,347,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ALGN. Sequoia Financial Advisors LLC boosted its holdings in Align Technology by 320.1% in the fourth quarter. Sequoia Financial Advisors LLC now owns 7,986 shares of the medical equipment provider’s stock worth $1,247,000 after acquiring an additional 6,085 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Align Technology by 35,513.8% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 545,604 shares of the medical equipment provider’s stock valued at $85,196,000 after acquiring an additional 544,072 shares in the last quarter. Capital International Ltd. CA increased its holdings in shares of Align Technology by 26.5% during the fourth quarter. Capital International Ltd. CA now owns 57,194 shares of the medical equipment provider’s stock valued at $8,931,000 after acquiring an additional 11,977 shares in the last quarter. Lecap Asset Management Ltd. purchased a new position in shares of Align Technology in the 4th quarter worth about $1,814,000. Finally, Merit Financial Group LLC raised its position in shares of Align Technology by 197.3% in the 4th quarter. Merit Financial Group LLC now owns 8,167 shares of the medical equipment provider’s stock worth $1,275,000 after purchasing an additional 5,420 shares during the last quarter. Institutional investors own 88.43% of the company’s stock.

Align Technology Price Performance

ALGN stock opened at $169.16 on Friday. The stock has a market capitalization of $12.12 billion, a P/E ratio of 29.42, a P/E/G ratio of 1.73 and a beta of 1.67. Align Technology, Inc. has a 1-year low of $122.00 and a 1-year high of $200.43. The business has a fifty day moving average price of $174.55 and a 200-day moving average price of $175.21.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, July 29th. The medical equipment provider reported $2.64 EPS for the quarter, beating the consensus estimate of $2.62 by $0.02. Align Technology had a return on equity of 15.86% and a net margin of 9.99%.The company had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same period last year, the firm posted $2.49 earnings per share. Align Technology’s revenue was up 4.3% compared to the same quarter last year. As a group, analysts anticipate that Align Technology, Inc. will post 9.48 earnings per share for the current year.

Align Technology declared that its board has authorized a stock repurchase plan on Wednesday, April 29th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to repurchase up to 1.6% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s leadership believes its shares are undervalued.

Key Align Technology News

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q2 results exceeded expectations. Align reported adjusted earnings of $2.64 per share and revenue of approximately $1.06 billion, topping consensus estimates. Revenue increased 4.3% year over year, while record Clear Aligner shipments and improved non-GAAP margins supported profitability. Align Technology Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Digital orthodontics remains a growth focus. Management highlighted expanding digital workflows, connected orthodontic tools and long-term opportunities for Invisalign, iTero scanners and exocad software. The company’s 2026 outlook was reaffirmed, while an orthodontic summit showcased its product and technology strategy. ALGN Q2 Earnings Call Highlights Digital Growth Push
• Positive Sentiment: Board changes could improve shareholder value. Following discussions with Elliott Investment Management, Align plans to add three independent directors and conduct an operational review. The initiatives may increase accountability, improve execution and identify opportunities to enhance returns. Align Technology to Overhaul Board Following Engagement with Elliott
• Neutral Sentiment: Valuation is viewed as more attractive after the pullback. Some analysts see ALGN as reasonably valued, but believe the stock needs faster growth to generate sustained upside. Align Technology: Attractively Valued, But Growth Still Needs To Pick Up
• Negative Sentiment: Near-term guidance and execution remain concerns. Third-quarter revenue guidance of roughly $1.0 billion was described as slightly below or around expectations, limiting the benefit of the earnings beat.
• Negative Sentiment: Systems weakness is capping upside. Analysts noted softer scanner and systems performance, along with pricing pressure, despite strong Clear Aligner volumes. Needham maintained a Hold rating. Align Technology Hold Rating Maintained
• Negative Sentiment: Growth is still relatively modest. Investors may remain cautious because revenue growth has not yet accelerated enough to justify a more bullish outlook, even with improving margins and record aligner shipments.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ALGN. Piper Sandler increased their price objective on shares of Align Technology from $220.00 to $235.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. Leerink Partners raised their price objective on shares of Align Technology from $225.00 to $230.00 in a research note on Thursday, April 30th. Weiss Ratings raised shares of Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. UBS Group reiterated a “neutral” rating and issued a $189.00 target price on shares of Align Technology in a research note on Thursday, July 23rd. Finally, Zacks Research cut shares of Align Technology from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 16th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, Align Technology has a consensus rating of “Moderate Buy” and an average price target of $206.36.

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.